sdz nvi-085 has been researched along with isradipine in 1 studies
| Studies (sdz nvi-085) | Trials (sdz nvi-085) | Recent Studies (post-2010) (sdz nvi-085) | Studies (isradipine) | Trials (isradipine) | Recent Studies (post-2010) (isradipine) |
|---|---|---|---|---|---|
| 10 | 1 | 0 | 1,403 | 346 | 86 |
| Protein | Taxonomy | sdz nvi-085 (IC50) | isradipine (IC50) |
|---|---|---|---|
| Voltage-dependent L-type calcium channel subunit alpha-1C | Oryctolagus cuniculus (rabbit) | 0.107 | |
| Voltage-dependent L-type calcium channel subunit alpha-1D | Rattus norvegicus (Norway rat) | 0.221 | |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | 0.0022 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boer, R; Eltze, M | 1 |
1 other study(ies) available for sdz nvi-085 and isradipine
| Article | Year |
|---|---|
The adrenoceptor agonist, SDZ NVI 085, discriminates between alpha 1A- and alpha 1B-adrenoceptor subtypes in vas deferens, kidney and aorta of the rat.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Aorta, Thoracic; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Clonidine; In Vitro Techniques; Isradipine; Kidney; Male; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; Norepinephrine; Oxazines; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Vas Deferens; Vasoconstriction | 1992 |